408 related articles for article (PubMed ID: 18495431)
1. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
[TBL] [Abstract][Full Text] [Related]
2. Quantity as an expression of quality: relationship between serum drug concentrations and quality of life.
Rieder M; Koren G
Ther Drug Monit; 2008 Oct; 30(5):557-8. PubMed ID: 18728626
[TBL] [Abstract][Full Text] [Related]
3. Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.
Pugh CB; Garnett WR; Poynor WJ; Pellock JM
Clin Pharm; 1984; 3(6):643-9. PubMed ID: 6439455
[TBL] [Abstract][Full Text] [Related]
4. [Problems in serum-level determination during valproic acid therapy].
Schäfer H; Reith H; Jacobs R; Gabriel KH
Arzneimittelforschung; 1977; 27(6):1215-21. PubMed ID: 332187
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in adolescents with well-controlled epilepsy.
Stevanovic D
Epilepsy Behav; 2007 Jun; 10(4):571-5. PubMed ID: 17416209
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire].
Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Barrera S; Morales MD;
Neurologia; 2008 Apr; 23(3):157-67. PubMed ID: 18370335
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
[TBL] [Abstract][Full Text] [Related]
9. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
Fudio S; Carcas A; Piñana E; Ortega R
J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
[TBL] [Abstract][Full Text] [Related]
10. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
11. Metabolic alterations during valproic acid treatment: a prospective study.
Abaci A; Saygi M; Yis U; Demir K; Dirik E; Bober E
Pediatr Neurol; 2009 Dec; 41(6):435-9. PubMed ID: 19931165
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
[TBL] [Abstract][Full Text] [Related]
13. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
[TBL] [Abstract][Full Text] [Related]
14. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
Dutta S; Reed RC
J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
[TBL] [Abstract][Full Text] [Related]
15. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
Fröscher W; Schulz HU; Gugler R
Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet.
Coppola G; Verrotti A; D'Aniello A; Arcieri S; Operto FF; Della Corte R; Ammendola E; Pascotto A
Acta Neurol Scand; 2010 Oct; 122(4):303-7. PubMed ID: 21077847
[TBL] [Abstract][Full Text] [Related]
17. Parental psychopathology and self-rated quality of life in adolescents with epilepsy in Nigeria.
Adewuya AO
Dev Med Child Neurol; 2006 Jul; 48(7):600-3. PubMed ID: 16780631
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
[TBL] [Abstract][Full Text] [Related]
19. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy.
Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E
Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443
[TBL] [Abstract][Full Text] [Related]
20. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
Aycicek A; Iscan A
Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
